News and Announcements
Read the latest news from Northwestern University Feinberg School of Medicine’s Department of Pharmacology and learn more about our faculty’s latest achievements, awards and honors.
A Northwestern University experimental therapeutic targeting a specific protein kinase reversed neurological symptoms in a mouse genetic model of autism, according to a recent Northwestern Medicine study.
Northwestern Medicine scientists have discovered how circulating tumor cells cluster together during metastasis — findings that reveal a novel mechanism for how cancer spreads and a potential new target for treatment.
According to a recent study, a group of four gene mutations seen only in people with African ancestry may contribute to an increased risk of severe bleeding while taking warfarin.
Targeting cancer cells with a transcription elongation inhibitor delayed tumor progression in animal models, according to a recent Northwestern Medicine study.
Gemma Carvill, PhD, assistant professor of Neurology, has been named a recipient of the NIH Director’s New Innovator Award, which funds highly innovative research proposals with the potential to transform their field.
Northwestern has been awarded a $12 million, five-year grant from the NIH for a research center dedicated to advancing the genetic understanding of epilepsy.
Hiroaki Kiyokawa, MD, PhD, professor of Pharmacology and of Pathology, was honored with a Dean's Teaching Award.
Northwestern Medicine scientists are using a variety of innovative techniques to uncover the epigenetics of breast cancer, as seen in three recent studies.
Northwestern Medicine scientists have discovered the activation mechanism of a calcium channel, providing new insights for future drug development targeting this calcium signaling pathway.
Novel research is changing the way we approach healthcare for mothers and their babies. Read the feature in Northwestern Medicine magazine.
Priscilla Yeung, a sixth-year student in the Medical Scientist Training Program (MSTP) studies calcium signaling in the laboratory of Murali Prakriya, PhD, professor of Pharmacology.
Novel research is changing the way we approach healthcare for mothers and their babies.
A Northwestern Medicine study has expanded the understanding of nicotine’s influences on the brain’s reward pathway, with implications for the development of anti-addiction therapies.
A team of scientists has discovered that in children with a severe form of epilepsy thought to be caused by a spontaneous mutation, about 10 percent of parents actually carry the same variant in a small proportion of their own cells.
Blocking a specific protein may reduce pain and reverse nerve degeneration caused by painful diabetic neuropathy, according to a recent study.
A Q&A with Alfred George, Jr., MD, chair of Pharmacology, director of the Center for Pharmacogenomics and the Magerstadt Professor of Pharmacology.
A team of scientists has developed a new technique that allows investigators to better study the effects of nicotine on brain cells.
- 03.15.2018Q&A with Brittany Hopkins, a fourth-year student in the Northwestern University Interdepartmental Neuroscience (NUIN) program, studying in laboratory of Richard J. Miller, PhD, the Alfred Newton Richards Professor of Pharmacology.
Investigators found two genes that modulate the severity of Long QT Syndrome, an inherited cardiac disorder that can cause heart arrhythmias and sudden death.
A new Northwestern Medicine study detailed a technique that could help scientists find the cause of cancer or autism-spectrum disease stemming from faulty protein disposal.
Northwestern Medicine investigators are on a mission to bring precision medicine to African-Americans.
Northwestern Medicine scientists are diving deep into the structure and function of ion channels to inform new therapies.
A new study explains how mutations in a sodium channel can lead to a disorder causing insensitivity to pain.
Northwestern Medicine scientists have mapped the complete structure of a voltage-gated sodium channel, proteins in the membrane of cells that play an important role in many diseases.
A Northwestern Medicine study has established a new safety index for a common group of chemotherapy drugs, by using a stem cell model to screen such therapies for cardiotoxicity.
Northwestern Medicine scientists identified the process by which a calcium channel called the CRAC channel opens and closes, and how mutations in the channel structures that control its opening cause disease.
Northwestern Medicine scientists have identified the unique targets of two enzymes that activate ubiquitination, a key modification of proteins that controls a variety of cellular processes.
Former and current colleagues, students and friends gathered to celebrated the career of Paula Stern, PhD, an authority on bone and mineral health research, and a respected leader and educator.
Northwestern Medicine scientists have demonstrated an alternate method of signaling used by proteins called group I metabotropic glutamate receptors, a finding that could be used to develop novel drug treatments for many neurological disorders.